A Mitochondria-Related Gene-Based Signature Predicts Pancreatic Ductal Adenocarcinoma Clinical Outcome and Revealed CAMK2A/THEM4 Regulates Progression Phenotypes and Mitophagy In Vivo and In Vitro

By
Jamie Kang
-
0
33
Researchers established a mitochondria-driven prognostic model for pancreatic ductal adenocarcinoma (PDAC) and identified the CAMK2A-THEM4-AKT axis as a novel therapeutic target.
[Journal of Translational Medicine]
Abstract